February 12, 2014
Japanese drugmakers Teijin Ltd. and Takeda Pharmaceuticals Co. Ltd. sued Indian rival Lupin Ltd. in Delaware federal court Wednesday, accusing it of infringing a Teijin-owned patent with its planned generic version of Takeda's gout treatment Uloric.